Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Quoin Pharmaceuticals Ltd
Net Income (Common)
Quoin Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Net Income (Common)
-$8.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
Compugen Ltd
NASDAQ:CGEN
|
Net Income (Common)
-$18.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-6%
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Net Income (Common)
-₪26m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
See Also
What is Quoin Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
-8.4m
USD
Based on the financial report for Mar 31, 2024, Quoin Pharmaceuticals Ltd's Net Income (Common) amounts to -8.4m USD.
What is Quoin Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-7%
Over the last year, the Net Income (Common) growth was 19%.